News

TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne ...
$6B valuation to bankruptcy: 23andMe acquired by nonprofit research institute TTAM, Anne Wojcicki announces
TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...
23andMe, Inc.: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
TTAM Research Institute ("TTAM"), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that ...
23andMe has officially been sold: What will happen to customers’ data?
After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.
23andMe is out of bankruptcy. You should still delete your DNA.
DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.
JD Supra15h
23andMe Bankruptcy Update: How the Proceedings Highlight Best Practices for Handling and Transferring Genetic Data and Personal Information
After Foley Hoag’s prior updates regarding the chapter 11 bankruptcy cases of 23andMe Holding Co and its affiliated debtors ...
Litigators of the Week: Getting 23andMe’s Bankruptcy Sale Past the Finish Line
After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...
JD Supra13h
23andMe Bankruptcy: The Privacy Ombudsman’s Report
The court-appointed Consumer Privacy Ombudsman (CPO) in the 23andMe bankruptcy last month released a 200-plus-page report ...
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
Today is last day for 23andMe customers to file claim against the company
North Carolina Attorney General Jeff Jackson successfully ensures 23-and-Me customers’ sensitive genetic information remains ...
23andMe data breach: Deadline looms for customers seeking compensation
To qualify for a cybersecurity-related claim, one must be a 23andMe customer between May 1, 2023, and Oct. 1, 2023; have received a notice that their personal information was compromised in the 2023 ...